Viewing Study NCT06081595


Ignite Creation Date: 2025-12-24 @ 2:07 PM
Ignite Modification Date: 2026-02-12 @ 2:13 PM
Study NCT ID: NCT06081595
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-10-13
First Post: 2023-10-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Fluzoparib Combined With Apatinib in Relapsed Ovarian Carcinoma Maintenance Treatment
Sponsor: Jin Li
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed Ovarian Cancer View
Keywords: